Aarti Drugs Share Price Target 2030: Future Forecast, Financials & Growth Outlook
Aarti Drugs Share Price Target 2030 to 2050: Aarti Drugs Limited is a leading Indian pharmaceutical company involved in manufacturing Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. Known for its strong domestic and international presence, the company plays a key role in the pharmaceutical supply chain.
Founded in 1984, Aarti Drugs is part of the Aarti Group and is listed on both NSE and BSE. It operates with a solid reputation for consistent performance and a customer-centric approach. In this article we analysis Aarti Drugs Stock Forecast, Fundamental and Growth.
Company Overview
| Company Name | Aarti Drugs Ltd |
|---|---|
| Founded | 1984 |
| Headquarters | Mumbai, India |
| Industry | Pharmaceuticals |
| MD | Mr. Rashesh C. Gogri |
| Stock Exchange Listing | NSE & BSE |
| Stock Name in NSE | AARTIDRUGS |
| Official Website | aartidrugs.co.in |
| Date of Listing | 19-Sep-2003 |
| Index | NIFTY TOTAL MARKET |
| Subsidiaries | Pinnacle Life Science Pvt. Ltd, Pinnacle Chile SpA, Suyash Laboratories Ltd |
Aarti Drugs Share Fundamental Metrics
| Market Cap | ₹4,308 Cr. | ROE | 12.28% |
| P/E Ratio | 25.9 | EPS (TTM) | 18.29 |
| P/B Ratio | 3.11 | Dividend Yield | 0.21% |
| Industry P/E | 33.79 | Book Value | 149 |
| Debt to Equity | 0.45 | Face Value | 10 |
| 52-Week High | ₹635 | 52-Week Low | ₹312 |
Read Also: KPI Green Share Price Target 2030 to 2050
Pros
Cons
- Valuation Alert: Stock is priced at 3.18x its book value — slightly on the higher side.
- Slow Growth: Sales have grown just 5.74% in the last 5 years.
- Average Returns: ROE over the last 3 years stands at a modest 13.8%.
- Interest Watch: Possibility of capitalizing interest costs on the books.
- Low Dividends: Payout ratio is just 5.45% over the last 3 years.
- Promoter Confidence Dip: Promoter holding dropped by 4.35% in 3 years.
Financial Overview 2025
Current Share Price
As of the latest data, Aarti Drugs stocks price is around ₹468
Aarti Drugs Share Price History of last 10 Years
Read Also: Rama Steel Tubes Share Price Target 2030 to 2050
Aarti Drugs Share holding pattern (As of March 2025)
As of Mar 2025 the shareholding data are as following:
| Yearly | Promoters | FIIs | DIIs | Public |
|---|---|---|---|---|
| Mar 2025 | 55.48% | 2.25% | 9.70% | 32.57% |
| Mar 2024 | 57.13% | 2.56% | 5.99% | 34.30% |
| Mar 2023 | 57.13% | 1.94% | 4.09% | 34.39% |
| Mar 2022 | 59.83% | 2.07% | 2.69% | 35.41% |
| Mar 2021 | 60.20% | 2.99% | 1.76% | 35.05% |
Aarti Drugs Share Price NSE Forecast 2025 to 2050
| Year | Target Price |
|---|---|
| Aarti Drugs Share Price Target 2025 | ₹550 |
| Aarti Drugs Share Price Target 2026 | ₹632 |
| Aarti Drugs Share Price Target 2027 | ₹727 |
| Aarti Drugs Share Price Target 2028 | ₹836 |
| Aarti Drugs Share Price Target 2029 | ₹920 |
| Aarti Drugs Share Price Target 2030 | ₹1196 |
| Aarti Drugs Share Price Target 2035 | ₹1375 |
| Aarti Drugs Share Price Target 2040 | ₹1581 |
| Aarti Drugs Share Price Target 2045 | ₹1819 |
| Aarti Drugs Share Price Target 2050 | ₹2274 |
Aarti Drugs Share Price Target 2025
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹550 | ₹355 | 2025 |
Aarti Drugs Share Price Target 2026
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹632 | ₹475 | 2026 |
Aarti Drugs Share Price Target 2027
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹727 | ₹654 | 2027 |
Aarti Drugs Share Price Target 2028
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹836 | ₹585 | 2028 |
Aarti Drugs Share Price Target 2029
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹920 | ₹735 | 2029 |
Aarti Drugs Share Price Target 2030
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹1196 | ₹956 | 2030 |
Aarti Drugs Share Price Target 2035
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹1375 | ₹1100 | 2035 |
Aarti Drugs Share Price Target 2040
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹1581 | ₹1265 | 2040 |
Aarti Drugs Share Price Target 2045
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹1819 | ₹1365 | 2045 |
Aarti Drugs Share Price Target 2050
| Maximum Target | Minimum Target | Year |
|---|---|---|
| ₹2274 | ₹1705 | 2050 |
Competitors / Peer Companies
- Sun Pharma.Inds.
- Divi’s Lab.
- Cipla
- Torrent Pharma.
- Dr Reddy’s Labs
- Mankind Pharma
- Alembic Pharma
Conclusion:
Aarti Drugs remains a stable pharma stock with long-term potential. While short-term returns may seem moderate, consistent revenue growth, capacity expansion, and a well-managed balance sheet indicate solid fundamentals. If you’re a long-term investor looking for sustainable returns, Aarti Drugs could be worth holding onto till 2030 and beyond.
Read Also: Aptus Share Price Target 2030 to 2050
FAQ
Is Aarti drugs a good buy?
Yes, with its strong API presence and export capabilities, Aarti Drugs is considered a fundamentally sound long-term stock.
What is the Aarti Drugs Share Price Target 2025?
Expected range is ₹550 – ₹355 depending on growth factors.
What is the Aarti Drugs Share Price Target 2026?
Expected range could be ₹632 – ₹475 depending on growth factors.
What is Aarti Drugs Share Price Target 2030?
Expected range could be ₹1196 – ₹955 depending on growth factors.
What is Aarti Drugs Share Price Target 2035?
Expected range could be ₹1375 – ₹1100.
What is Aarti Drugs Share Price Target 2040?
Expected range is ₹1581 – ₹1265 depending on growth factors.
What is Aarti Drugs Share Price Target 2050?
If current growth continues, could reach ₹2274 – ₹1705 by 2050.
Does Aarti Drugs stocks pay dividends?
Yes, the company has a history of regular dividends, though the yield is modest.
Disclaimer: The stocks mentioned above are shared purely for informational and research purposes. We are not authorized by SEBI (Securities and Exchange Board of India).These are not investment recommendations. Please make sure to do your own research or consult a financial advisor before making any investment decisions.
